ArticleSurgical neurology international2025
Feasibility of redo endoscopic microvascular decompression for recurrent trigeminal neuralgia: An illustrative case.
Article in Surgical neurology international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Trigeminal neuralgia (TN) is often treated with microvascular decompression (MVD), providing long-term pain relief for most patients. However, a subset experiences recurrence requiring reoperation. Endoscopic MVD techniques have gained traction due to enhanced visualization and potentially lower morbidity, yet their feasibility for redo procedures - particularly in complex cases with dense adhesions - remains uncertain. Case Description: We report the case of a 63-year-old male who initially presented with Barrow Neurological Institute (BNI) grade V TN in the V2-V3 distribution. After an endoscopic MVD, the patient achieved immediate pain relief (BNI I) but developed recurrent symptoms 10 months later (BNI III), controlled by carbamazepine. A subsequent escalation (BNI IV) prompted surgical re-exploration. Imaging revealed no residual or new neurovascular conflict. Instead, intraoperative findings demonstrated dense adhesions tethering the trigeminal nerve to the tentorium, causing nerve tension. Careful endoscopic dissection restored nerve mobility and resulted in complete symptom resolution. Conclusion: This case highlights the feasibility and effectiveness of a fully endoscopic redo MVD in recurrent TN where dense adhesions, rather than persistent vascular compression, were the primary mechanism of recurrence. Further investigation is warranted to optimize endoscopic techniques, reduce adhesion formation, and improve long-term outcomes in redo MVD cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.